Kendall, Michelle A <br/><br/>
A reduced frequency visit schedule underreports adverse events that resulted in dose modifications or treatment discontinuations in HIV/AIDS clinical trials: ACTG DACS 207.  [electronic resource] 

 -  Contemporary clinical trials  Jun 2006 
 - 287-94 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1551-7144 
<br/><br/><label>Standard No.: </label>10.1016/j.cct.2006.02.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Retroviral Agents--adverse effects<br/>Clinical Trials as Topic<br/>Data Interpretation, Statistical<br/>Drug Monitoring<br/>Female<br/>HIV Infections--drug therapy<br/>Health Status<br/>Humans<br/>Male<br/>Office Visits--statistics & numerical data<br/>Retrospective Studies